Trial · NCT05732883
Registered outcomes40
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 40
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Post-operative calcium and parathyroid hormone level on POD1 | Post-op 1 day | Serum calcium and parathyroid hormone level will be monitored |
| Primary | Post-operative calcium and parathyroid hormone level after 3 months post-op | Post-op 3 months | Serum calcium and parathyroid hormone level will be monitored |
| Primary | Post-operative calcium and parathyroid hormone level after 6 months post-op | Post-op 6 months | Serum calcium and parathyroid hormone level will be monitored |
| Primary | Voice Handicap Index (VHI-10) | Post-op 1 week | Subjective voice assessment consisting of 10 questions. Each question 0-4 score |
| Primary | Voice Handicap Index (VHI-10) | Post-op 3 months | Subjective voice assessment consisting of 10 questions. Each question 0-4 score |
| Primary | Voice Handicap Index (VHI-10) | Post-op 6 months | Subjective voice assessment consisting of 10 questions. Each question 0-4 score |
| Primary | Perceptual Evaluation: Cantonese Perceptual Evaluation of Voice (CanPEV) | Post-op 1 week | Objective voice assessment consisting of 10 questions. Each question 1-10 score. 1 being normal and 10 being the most severe voice dysfunction |
| Primary | Perceptual Evaluation: Cantonese Perceptual Evaluation of Voice (CanPEV) | Post-op 3 months | Objective voice assessment consisting of 10 questions. Each question 1-10 score. 1 being normal and 10 being the most severe voice dysfunction |
| Primary | Perceptual Evaluation: Cantonese Perceptual Evaluation of Voice (CanPEV) | Post-op 6 months | Objective voice assessment consisting of 10 questions. Each question 1-10 score. 1 being normal and 10 being the most severe voice dysfunction |
| Primary | Acoustic Evaluation | Post-op 1 week | Instruct patient to sustain vowel /a/ and to read aloud the Hong Kong passage at a comfortable pitch and loudness level for about 3-5 seconds. Keep a distance of 15cm from the microphone for recording. Highlight the middle 3 seconds for analysis. To assess the fundamental frequency (Hz) and performance (dB) |
| Primary | Acoustic Evaluation | Post-op 3 months | Instruct patient to sustain vowel /a/ and to read aloud the Hong Kong passage at a comfortable pitch and loudness level for about 3-5 seconds. Keep a distance of 15cm from the microphone for recording. Highlight the middle 3 seconds for analysis. To assess the fundamental frequency (Hz) and performance (dB) |
| Primary | Acoustic Evaluation | Post-op 6 months | Instruct patient to sustain vowel /a/ and to read aloud the Hong Kong passage at a comfortable pitch and loudness level for about 3-5 seconds. Keep a distance of 15cm from the microphone for recording. Highlight the middle 3 seconds for analysis. To assess the fundamental frequency (Hz) and performance (dB) |
| Primary | Aerodynamic Evaluation (Maximum sustained phonation) | Post-op 1 week | Instruct patient to sustain vowel /a/ at a comfortable pitch and loudness level for as long as possible after taking a deep breath. Recorded in seconds |
| Primary | Aerodynamic Evaluation (Maximum sustained phonation) | Post-op 3 months | Instruct patient to sustain vowel /a/ at a comfortable pitch and loudness level for as long as possible after taking a deep breath. Recorded in seconds |
| Primary | Aerodynamic Evaluation (Maximum sustained phonation) | Post-op 6 months | Instruct patient to sustain vowel /a/ at a comfortable pitch and loudness level for as long as possible after taking a deep breath. Recorded in seconds |
| Secondary | Calcium and Rocaltrol requirement | Post-op 1 week | The required dosage of Calcium Carbonate and Rocaltrol will be documented |
| Secondary | Calcium and Rocaltrol requirement | Post-op 3 months | The required dosage of Calcium Carbonate and Rocaltrol will be documented |
| Secondary | Calcium and Rocaltrol requirement | Post-op 6 months | The required dosage of Calcium Carbonate and Rocaltrol will be documented |
| Secondary | Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 | Post-op 1 week | Number of participants experiencing side effects from Dexamethasone will be documented |
| Secondary | Stroboscopic Assessment (Vocal Fold Edge) | Post-op 1 week | Score 1-5 (1 - Smooth and straight; 5 - Rough and irregular) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05732883/registered